Joseph DeRisi, PhD, and Allison Doupe, MD, PhD were honored by the National Academy of Sciences for their “extraordinary scientific achievements” yesterday. They join 13 others in the fields of physical, biological and social sciences.
January 17, 2014
November 26, 2012
Decreasing the level of a key brain protein led to significantly less drinking and alcohol-seeking behavior in rats and mice that had been trained to drink, according to a study by researchers at the Ernest Gallo Clinic and Research Center at UCSF.
September 13, 2012
Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.
June 13, 2012
A UCSF husband-and-wife research team, Lily Jan and Yuh Nung Jan, will be awarded a major neuroscience award — the Gruber Foundation Neuroscience Prize — for their key insights into the development and function of the nervous system.
May 20, 2012
UCSF scientists have shown that a key brain structure in the Bengalese finch acts as a learning hub, receiving information that helps to improve its song, a finding which may lead to new ways to treat neurological disorders that impair movement such as Parkinson’s disease.
May 07, 2012
Old-time fiddler Heidi Clare Lambert, artist in residence at UCSF’s Memory and Aging Center, is part of the unique Hellman Visiting Artist Program, which was created to foster dialogue about creativity and the brain.
April 06, 2012
Nobel laureate Stanley Prusiner will talk about his prize-winning research about prions during the UCSF Osher Mini Medical School for the Public on April 16.
November 14, 2011
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
October 14, 2011
The only medication currently approved for stroke treatment – tissue plasminogen activator (tPA), which dissolves blood clots – is associated with an increased risk of bleeding in the brain, particularly among patients with hyperglycemia (high blood sugar).